Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F1AZ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,686
Award facts
- Contract value 100% obligated
- $23,686.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a $23.7K delivery order to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits, with performance scheduled for completion by January 30, 2026. This was a competitively awarded, firm fixed-price contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies and medications to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The CIMZIA delivery—a biologic immunosuppressant used for rheumatologic and inflammatory conditions—reflects AmerisourceBergen's ongoing role in supplying specialty medications to military treatment facilities and veteran healthcare systems through its prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26F1AZ6?
SPE2DR26F1AZ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AZ6 worth?
The government has obligated $23,686 on SPE2DR26F1AZ6.
Is contract SPE2DR26F1AZ6 an order under another contract?
Yes. SPE2DR26F1AZ6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AZ6 competed?
The extent of competition for SPE2DR26F1AZ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award